“A new study published on Aug. 31 in Proteomics Clinical Applications found spike protein in the biological fluids of people who received an mRNA COVID-19 vaccine six months after vaccination, suggesting mRNA may be integrated or retranscribed in some cells. Researchers detected specific fragments of synthetic spike protein in about 50 percent of subjects who received mRNA vaccines. The synthetic spike protein was detected from 69 to 187 days following vaccination. All samples from the unvaccinated control group were negative, including the 20 individuals who had tested positive after contracting COVID-19.”
Bud is a retired life sciences executive. Bud's entrepreneurial leadership exceeded three decades. He was the senior business development, marketing and sales executive at four public corporations, each company a supplier of analytical and life sciences instrumentation, software, consumables and service. Prior to those positions, his 19 year career in Hewlett-Packard Company's Analytical Products Group included worldwide sales and marketing responsibility for Bioscience Products, Global Accounts and the International Olympic Committee, as well as international management assignments based in Japan and Latin America. Bud has visited and worked in more than 65 countries and lived and worked in 3 countries.
budbromley 